Reduced Shedding of Surface Mesothelin Improves Efficacy of Mesothelin-Targeting Recombinant Immunotoxins
Molecular Cancer Therapeutics - United States
doi 10.1158/1535-7163.mct-15-0863
Full Text
Open PDFAbstract
Available in full text
Date
May 18, 2016
Authors
Publisher
American Association for Cancer Research (AACR)